Thanks, Chair.
I just want to follow up on a few points that were made.
When Mr. Valeriote was talking he was leaving the impression I think that if the committee doesn't pass this motion, we're somehow shutting down debate and not letting people have their word.
But, Chair, I want to go back to the timeline on this bill, because I think it's extremely important. It was tabled in the House in November 2009; that would be one whole year ago, 12 months. It was referred to committee in April 2010, and now we're sitting in October 2010. There has been debate in the House on this private member's bill to get it to committee. There has been intense lobbying done by the agricultural sector. And, quite frankly, Chair, there's been debate here in committee. We've had witnesses come forward on this bill.
So I think the important thing, Chair, is that this is not shutting down debate. What they're asking to do is prolong debate. That's what the motion is about. It's not about shutting down debate; they want to prolong debate.
The question I ask, especially to the Liberals, because they are the swing vote on this, is why? Why do you want to prolong debate?
Chair, here's the issue. The issue is that we're talking about legislation here, something that will actually change an act. If you want to have the debate, you can have the debate without legislation being the crux of the matter. This is what the industry is worrying about, that this legislation will pass. That's what they're worried about.
Mr. Valeriote and Mr. Hoback have put together a joint motion to study biotech. There's no legislation involved with that. It would be a committee study of biotech. It's a perfect opportunity to have the debate on biotech, on matters such as what Mr. Atamanenko is proposing, without the heavy hammer of potential legislation passing into law. That's the difference.
So they're asking, first of all, to prolong this debate on a bill that could have a very detrimental impact on the industry when what we could do is pass a motion that the next committee study is on biotech. We could have the same debate, Chair, and in fact have a more expanded debate without legislation being on the table, without legislation striking fear into the industry, because if this bill passes, it will have a very detrimental impact on the industry.
I want to highlight this. We know this because we have had leaders from farm groups come and see us. Last week, or a week and a half ago, we had the biotech industry into our offices. They were meeting with me, meeting with my colleagues, meeting with the Liberals, meeting with the NDP and with the Bloc. I can tell you, they're worried; they're very worried about this bill and where it's going. And they're confused, because on the one hand the Liberals say, “We're against the bill”.... Actually, that was a bit of a revelation. That's the first I've heard that concretely on the record, that the Liberals are against the legislation. On the other hand, Chair, they're going to vote for the motion.
It simply doesn't make any sense. I think the industry sees that that position makes no sense. If you are against the bill, vote against the bill. Vote against prolonging the debate, prolonging the agony in which the industry finds itself. Vote against prolonging turmoil within the industry.
If you remember our last witness, Chair, we had Wilfred Keller in from Genome, and that was the question I asked him. He's in the marketplace, he's in the industry. I asked him, based on his experience, is the very debate on this bill having a detrimental impact on the industry? That was my question. And his answer was yes.
Why this debate should be prolonged makes no sense, Chair. And if we're going to prolong the debate, that's only going to prolong the misery within that portion of the agricultural sector.
The second last thing I'll bring up is that Mr. Valeriote is from Guelph. As we know, Chair, universities are very keen on research and development. They look for opportunities to make advances, particularly in agriculture. We've been to the University of Guelph. We've toured their facilities. We've spoken with their heads of departments as a committee. They're very clear about it. They are for research and development and moving the yardsticks forward for the agricultural community. Yet this bill throws that into turmoil. So I'm unclear as to why Mr. Valeriote would prolong the uncertainty, particularly when he's from a riding that contains the University of Guelph.
The last point I'll make on this, Chair, is that we all know how we're going to vote now. We know the NDP, obviously, are for the bill. It's an NDP private member's bill. The NDP are probably going to be for that. We know that we are against. We've always been against the bill. We've been very clearly against the bill, both in the House and here in committee. And we've just heard the Liberals say they are against the bill.
So the cards are on the table, Chair. There is no need to prolong this. If we want the debate to continue, let's have it continue on a biotech study, not on a bill when that bill is having a detrimental impact on the industry.
Again, I would appeal to my Liberal colleagues to see the reasonableness of this argument, and I know they have heard it from industry. So I would encourage them, Chair, to vote against this motion to prolong debate, because debate has happened.
Instead, what we could do is this. There are meetings left before the 60 sitting days expire in which the bill has been before committee; there is still more time for witnesses to come forward. Let's call those witnesses forward. Let's have our debate during the allocated timeframe.
Let's vote against this motion. Let's get this bill back to the House and let's just deal with it. Then, as a committee, let's move forward with the joint biotech study, which shows there is cooperation here. Yes, we have a disagreement on this bill, but there is cooperation in this committee and we've seen the good work that we're able to do. Let's continue the debate on a study, without the threat of legislation.